Source link : https://newshealth.biz/health-news/first-targeted-therapy-for-exon-20-insertions-in-nsclc-wins-fda-accelerated-approval/
(MedPage Today) — The FDA granted accelerated approval to the tyrosine kinase inhibitor sunvozertinib (Zegfrovy) for advanced non-small cell lung cancer (NSCLC) associated with EGFR exon 20 insertions, the agency said. The approval stipulates… Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/116393 Author : Publish date : 2025-07-07 17:59:00 Copyright for syndicated content belongs to the linked Source.
The post First Targeted Therapy for Exon 20 Insertions in NSCLC Wins FDA Accelerated Approval first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-07 17:59:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8